1999 to 2019 Saw Increase in Substance Use+CVD-Related Mortality
11 Jan 2024
AHAClinical Study
THURSDAY, Jan. 11, 2024 -- From 1999 to 2019, there was an increase in mortality related to substance use (SU) plus cardiovascular disease (CVD), according to a study published online Jan. 10 in the Journal of the American Heart Association.
Abdul Mannan Khan Minhas, M.D., from the University of Mississippi Medical Center in Jackson, and colleagues identified SU+CVD-related deaths using Multiple Cause-of-Death Public Use record death certificates and examined trends in mortality.
There were 636,572 SU+CVD-related deaths between 1999 and 2019. The researchers found the age-adjusted mortality rates were pronounced in men, in American Indian or Alaska Native individuals, in nonmetropolitan/rural areas, and for alcohol-related deaths (22.5, 37.7, 15.2, and 9.09 per 100,000 population, respectively). From 1999 to 2019, there was an increase observed in overall SU+CVD-related age-adjusted mortality rates from 9.9 to 21.4, with an average annual percent change of 4.0. Across all subgroups, there were increases seen in SU+CVD-related average annual percent changes, which were pronounced among women (4.8 percent) and for American Indian or Alaska Native individuals, younger individuals, nonmetropolitan areas, and cannabis and psychostimulant users.
"We would like to see additional public health efforts to support comprehensive evaluation and management of substance use in the U.S. that includes clinician and patient education, as well as attention to socioeconomic factors that contribute to substance use," senior author Dmitry Abramov, M.D., from the Loma Linda University Medical Center in California, said in a statement.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.